Category: NeuWave Medical Inc.
Here's a look at some of the top legal news stories for medical device companies this week: NeuWave Med raises $25m; Medtech funding in today's environment; Medtech trio sets $297m offering terms; AirXpanders plans $28m IPO Down Under; ClarVista raises $14m Series B round
NeuWave Medical raised more than $25 million in equity financing as it works to advance the market for its microwave ablation tumor removal tool.
UPDATED May 28, 2015, with details on investors, comment from management.
NeuWave Medical – developer of a microwave ablation tumor removal tool – pulled in more than $25.3 million in a Series C round led by Versant Ventures.
NeuWave has $5 million left to raise before hitting its target in a hoped-for $19 million funding round.
Wisconsin medical device maker NeuWave Medical is more than halfway to wrapping up a hoped-for $19 million equity funding round, with $14 million in the bank so far and 22 accredited investors, according to an SEC filing.
The new filing offered more details on a fundraising round that began almost 1 year ago. As of yesterday, the ablation device company has about $5 million left to go to top off the fund-raise.
Four medical device companies raise more than $70 million recently, with investors backing technologies ranging from a laser scalpel to a pancreatic stent.
Four medical device companies reeled in more than $70 million in recent weeks, to develop technologies including a laser scalpel for minimally invasive surgeries, a peripheral vessel stapler, a thermal ablation system and a biliary stent.
Cambridge, Mass.-based OmniGuide led the charge with a $35 million round from Orbimed Advisors. OmniGuide chairman Yoel Fink told MassDevice.com in 2010 that the device uses the mirror technology he pioneered at the Mass. Institute of Technology in the 1990s.
, 180 Medical
, Intact Vascular
, NeuWave Medical Inc.
, Premier Inc.
Here's a roundup of the latest dealflow and investment news: